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INTRODUCTION
Research on trefoil factor family (TFF) peptides started 
in 1982, when pancreatic spasmolytic polypeptide, today 
known as TFF2, and sP2 peptide, today known as TFF1 were 
discovered [1]. A few years later, intestinal trefoil factor (now 
TFF3) was described. A three-looped, clover-like structural 
domain is a common characteristic of these peptides, and 
is important for their resistance to proteolytic degrada-
tion [2,3]. Members of this small family of peptides are pre-
dominantly found in mucous epithelia of the gastrointestinal 
system. However, they are also expressed in many other tis-
sues, for example epithelia of respiratory tract, uterus, con-
junctiva, thyroid gland, salivary glands, prostate, mammary 
gland, gallbladder, and thyroid gland [2–4]. Expression of 
these peptides was investigated in connection with diﬀ erent 
pathological conditions. It has been found that expression of 
TFF peptides is deregulated in numerous epithelial tumors 
[4–9] and chronic inﬂ ammatory diseases  [10–13]. Th ese 
peptides act through various mechanisms and participate 
in apoptosis, cell migration, and immune response, aﬀ ect 
mucus viscosity and angiogenesis [4,7,11,14-16]. New prop-
erties and potential roles of TFF peptides are continually 
being discovered, making them a fruitful ﬁ eld for scientiﬁ c 
research.
TFF1 and TFF3 are both found in the nervous tissue, how-
ever, to a much lower extent than in the mucous epithelia. Both 
peptides are expressed in diﬀ erent parts of adult rat, mouse, 
and human brain. Signiﬁ cant TFF1 expression was noticed 
in rat hippocampus, frontal cortex, and cerebellum [17], and 
weak, but uniform expression was detected in all regions of 
mouse brain [18]. In mouse and rat, astrocytes have been 
reported to synthesize TFF1 [17,19,20]. Th ere are very limited 
data on the neural expression of TFF2, which is the least inves-
tigated of the three TFF peptides in the context of neural tissue. 
Until now, TFF2 was found in the ganglion cell layer of murine 
retina, which is of neural origin [21], whereas regarding TFF3, 
mouse brain shows signiﬁ cant expression of this peptide in 
hippocampus, temporal cortex and cerebellum [18]. TFF3 
was also detected in human and rat hypothalamus, particu-
larly in the supraoptic and paraventricular nuclei, co-localized 
with oxytocin, and accumulated together with oxytocin in the 
neural lobe of pituitary [22–24]. Ultrastructural examination 
of porcine pituitary gland revealed co-localization of TFF3 
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and oxytocin within the same vesicles, and was thus hypothe-
sized that from there, TFF3 is released into the bloodstream to 
aﬀ ect potential, undiscovered target receptors [25]. Injections 
of TFF3 monomer into rat amygdala exhibit a dose-depen-
dent eﬀ ect on animal behavior (anxiolytic eﬀ ect at low dose 
or anxiogenic eﬀ ect at high dose) [24]. Recent research iden-
tiﬁ es TFF3 as a neuropeptide that facilitates learning, object 
recognition and retention of memory [26]. Low TFF3 in cere-
brospinal ﬂ uid is a predictive factor for brain atrophy, and its 
potential role in the pathogenesis of Alzheimer’s disease is 
suggested [27].
Since TFF1 and TFF3 are found in the adult brain of mice 
and rats, it is interesting to investigate their expression in 
mouse embryonic nervous tissue, and also to screen for their 
presence in the neurons of the peripheral nervous system both 
in adult animals and embryos. Th e aim of our study was to 
investigate the presence of TFF1 and TFF3 in nervous tissues 
of the mouse embryo. Expression of TFF2 was not investigated 
in this study, because TFF1 and TFF3 were of main interest in 
recent nervous system research in adult animals. However, 
this could be a subject of future research on TFF peptides.
MATERIALS AND METHODS
Th e use of the animals was reviewed and approved by 
the Croatian board for scientiﬁ c animal experiments and 
approved by a local ethical committee. Twelve CD1 mouse 
embryos 15, 16 and 17  days old (Th eiler stage 23, 24 and 25) 
were used in this study (ﬁ ve 15-day old, four 16-day old and 
three 17-day old embryos). Embryos of a speciﬁ c age in our 
collection were obtained in the following manner: after 
placing the females and males in the same cage, vagina was 
checked for the vaginal plug every morning. Th e presence of 
the vaginal plug was considered the beginning of pregnancy 
(gestational day 0). On a particular day, depending on the age 
of embryos required, the females were sacriﬁ ced by cervical 
dislocation.
Embryos were isolated, ﬁ xed in 4 paraformaldehyde, and 
then embedded in paraﬃ  n. Prepared paraﬃ  n blocks were cut 
sagittally into 6 μm thick sections that were transferred onto 
adhesive slides, and sections from all embryos were carefully 
selected to show nervous tissues of interest. Slides were dried, 
deparaﬃ  nized and rehydrated. Epitope retrieval was per-
formed by heating in the microwave for around ﬁ ve minutes, 
using 0.01 M citric acid (pH 6). Blocking of endogenous per-
oxidase was done using 0.3 hydrogen peroxide for 15  min. 
Non-speciﬁ c protein blocking was made with SuperBlock® 
(Th ermo Scientiﬁ c, Rockford, USA) for 30  min. Aﬃ  nity 
puriﬁ ed primary polyclonal rabbit anti-TFF1 and anti-TFF3 
antibodies (proprietary, self-made) were applied to separate 
slides, which were incubated at 4° C until tomorrow morning. 
Th e antibodies were puriﬁ ed by immunoadsorption from 
the serum, validated by Western blotting and speciﬁ city was 
conﬁ rmed by immunostaining of the speciﬁ c sections of the 
alimentary tract. All the antibodies were produced accord-
ing to the speciﬁ c peptide sequence. Antibody dilutions 
used were 1:250, 1:500 and 1:1000 for anti-TFF1, and 1:2500, 
1:5000 and 1:10000 for anti-TFF3. Phosphate-buﬀ ered saline 
(PBS) (pH 7.4) was used as a negative control (primary anti-
body omitted), and for the dilution of antibodies as well. Best 
results were obtained using 1:500 antibody dilution for TFF1 
peptide, and 1:5000 for TFF3 peptide. Sections of adult mouse 
stomach were used as a positive control for TFF1 staining, 
and adult mouse intestine for TFF3 staining. Next day, slides 
were rinsed with PBS+0.05 Tween (Sigma–Aldrich, St. 
Louis, MO, USA) four times for 5 minutes and after that bioti-
nylated goat anti-rabbit secondary antibody (Dako, Glostrup, 
Denmark) was applied for 30 minutes at room temperature. 
After another four rounds of ﬁ ve-minute washes in PBS+0.05 
Tween, Streptavidin-HRP (Dako, Glostrup, Denmark) was 
applied to the slides for 30  minutes at room temperature. 
Slides were further rinsed four times in PBS+0.05 Tween, 
after which ﬁ nal exposure to DAB (3,3’-diaminobenzidine) 
was performed (Sigma–Aldrich, St. Louis, MO, USA). Slides 
were then washed with PBS+0.05 Tween, counterstained 
with hematoxylin, dehydrated and mounted with Canada 
balsam.
Th e following nervous tissues were examined: brain, 
spinal cord, dorsal root ganglia and cerebral ganglia (if avail-
able). Tissues at diﬀ erent developmental stages were analyzed 
manually using light microscopy at magniﬁ cations 20×, 40×, 
100×, and 400×, and photographed at 400×. Slides were mon-
itored with Olympus® BX50 microscope, photographed using 
Olympus® C-5050 digital camera and QuickPHOTO PRO 
imaging software (Promicra s.r.o., Prague, Czech Republic). For 
image assembly, Paint.NET software was used (version 4.0.5., 
dotPDN LLC, Rick Brewster and contributors).
RESULTS
Sections revealed diﬀ erent parts of the nervous system 
of the embryos. Morphologically, no abnormalities were 
detected, and the nervous tissues were in line with the devel-
opmental stages of the embryos. Presence of TFF1 and TFF3 
peptides was detected in diﬀ erent parts of embryonic nervous 
system at all examined stages, from day 15 to day 17. Brain, spi-
nal medulla, spinal ganglia and in some cases cerebral ganglia 
were available for examination.
TFF1 peptide was found in the ganglion cell somata in 
the dorsal root ganglia and trigeminal ganglion. Th e signal 
was present in the cytoplasm of neurons, mostly sparing the 
nucleus (Figure  1A). Also, a mild to moderate TFF1 signal 
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was detectable in the whole central nervous system, in the 
white matter, glial cells and neurons of the brain and spinal 
medulla (Figures 2A and 3A). Th is signal was diﬀ usely  present, 
 consistently appearing on all sections. TFF3 peptide was pres-
ent both in the cytoplasm and the nucleus of ganglion cells 
of trigeminal ganglion and dorsal root ganglia (Figure  1B). 
Positive staining for TFF3 peptide was also detected in the 
cytoplasm and nucleus of neurons occupying diﬀ erent nuclei 
of brain and medulla oblongata (Figure 2B). As for the spinal 
cord, neurons in the gray matter of spinal cord were also pos-
itive in the same manner (Figure 3B). At day 17, the staining 
for TFF3 peptide was more cytoplasmic than nuclear. Some 
gentle staining for TFF3 peptide was visible in the white mat-
ter of the embryonic central nervous system. Choroid plexus 
was both TFF1 peptide and TFF3 peptide positive (not shown 
in ﬁ gures).
Th ere were no diﬀ erences in the staining pattern at the dif-
ferent stages of embryonic development. All negative controls 
showed no immunostaining, and all positive controls showed 
typical staining both for TFF1 and TFF3 peptide (not shown 
in ﬁ gures).
DISCUSSION
Th e presence and localization of TFF1 and TFF3 pep-
tides in the neural tissue at diﬀ erent stages of development 
was investigated using immunohistochemistry. Trefoil fac-
tors TFF1 and TFF3 were detected in mouse brain and spinal 
medulla at developmental stages E15-E17. At this point, we 
investigated the later stages of the embryonic development 
since they are morphologically and functionally closer to that 
of adult animals, and, therefore, more comparable to data cur-
rently available.
Although consistent with that of adult animals [18,20], 
detailed localization of TFF1 and TFF3 peptides in a devel-
oping brain was not determined in this study. However, we 
showed for the ﬁ rst time that TFF peptides can be located 
in the peripheral nervous tissue. Both examined molecules 
were found in ganglion cell somata: TFF1 peptide mostly in 
the cytoplasm and TFF3 peptide in the cytoplasm and the 
nucleus.
In our study, positive staining for TFF1 and TFF3 peptides 
was detected at similar developmental stages as the expres-
sion of TFF genes observed in developing mouse brain by 
other researchers (E16-E18) [18]. In adult nervous tissue, TFF1 
gene was expressed at low level nearly uniformly in all brain 
regions, while TFF3 gene which was located in cerebral cortex 
and cerebellum before birth, was restricted to hippocampus, 
temporal cortex and cerebellum after birth [18]. Expression 
of TFF1 mRNA in the rat hippocampus reaches maximum 
around the birth [2].
FIGURE  1. Presence of TFF1 and TFF3 in the dorsal root gan-
glion cells of mouse embryos. A TFF1 staining; B TFF3 staining. 
Magniﬁ cation 400×.
A
B
FIGURE 2. TFF1 and TFF3 signal in the brain of mouse embryos. 
A TFF1 staining, hippocampus; B TFF3 staining, olfactory bulb. 
Magniﬁ cation 400×.
A
B
FIGURE 3. Positive staining for TFF1 and TFF3 in the neurons of 
embryonic spinal medulla. Cytoplasmic staining and a diﬀ use 
signal in the white matter for TFF1 and TFF3 localization in the 
nucleus and cytoplasm of the neurons in the grey matter. A TFF1 
staining; B TFF3 staining. Magniﬁ cation 400×
A
B
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Th e role of TFF peptides in the nervous system is still 
not fully understood. Th e presence of TFF3 peptide in por-
cine  [25] and human [22] oxytocinergic neurons suggests 
their role as a neurotransmitter/modulator in various brain 
regions innervated by these neurons, like brain stem, spi-
nal cord and pontine tegmentum [2], or as a neurohormone 
released into bloodstream and aﬀ ecting potential target cells. 
Recent research has revealed various behavioral eﬀ ects of 
TFF3 peptide. It aﬀ ects anxiety bidirectionally in dose-depen-
dent manner and improves learning and object recognition 
 memory  [24,26]. In our study, TFFs were found in diﬀ erent 
neuron somata, and (especially TFF1 peptide) diﬀ usely in the 
white matter of the central nervous system. Th ese results point 
to a possibility that TFFs may act as neuromodulators and/or 
neurotransmitters even during embryonic development.
Presence of TFF peptides in developing neural tissues 
raises questions regarding their possible role in the nervous 
tissue development. Since TFF peptides were associated 
with oxytocin secretion in neural tissue and mucin secre-
tion in goblet cells [20], there is a possibility that TFFs may 
be markers for physiological maturation of speciﬁ c tissues and 
cells. If this is the case, they might be used as an embryonic 
mark to pinpoint the start of an active physiological func-
tion. Th ere is, however, another potential developmental role 
for TFF peptides. Research shows that they are also involved 
in cell proliferation and migration [15]. Th ese processes are 
indispensable for the development of central nervous sys-
tem. Since cell proliferation and migration are of particular 
importance in embryonic development, presence of TFFs in 
the developing nervous system goes well with similar roles of 
these peptides already demonstrated in adult tissues. For this 
reason, our results support the theory that TFFs might have 
an active role in nervous tissue development. Th ere is also a 
possibility that TFF peptides are involved in development and 
plasticity of neural tissue through mechanisms responsible 
for their protective eﬀ ects in epithelial tissues, for example, 
in the case of gastrointestinal mucosal protection and resti-
tution  [20]. Otto and Patel showed that all three TFFs were 
up-regulated in response to physical wounding of embryo-
logical gut (E17-18], but the expression showed diﬀ erences in 
the adult  [28]. Identiﬁ cation of novel rodent gene encoding 
for neural regeneration protein, which contains domain with 
homology to survival-promoting peptide (SPP) and TFF1 pep-
tide, and exerts biological activities as neural migration, pro-
liferation, diﬀ erentiation, enhancement of neurite outgrowth 
and promotion of neuronal survival [29], supports proposed 
active role of TFF peptides in neural development and pro-
tective function.
Considering various eﬀ ects of TFF peptides in cell migra-
tion, proliferation, apoptosis and angiogenesis, and the pattern 
of their expression in developing nervous system, it can be 
concluded that TFF peptides might be involved in complex 
processes of nervous system development and diﬀ erentiation, 
and brain plasticity. Th ese preliminary results suggest further 
research in order to elucidate these peptides’ features in the 
nervous tissues and embryonic development. Such research is 
important, since mechanisms of embryonic development can 
sometimes be linked to pathological processes leading to dif-
ferent debilitating diseases [30], and embryological research 
can suggest novel regenerative therapies [31]. Possible next 
steps would be to investigate TFF protein expression at the 
earlier stages of embryonic development, and also to inves-
tigate if TFF2 is expressed in adult and embryonic nervous 
system, both of which may be interesting for future research.
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